Fibronectin gene polymorphisms in HCV related type II mixed cryoglobulinemia: risk of development of B-cell lymphoma
- 31 May 2018
- journal article
- research article
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 27 (5) , 1389-1395
Abstract
No abstract availableKeywords
Funding Information
- theodor bilhars research institute
This publication has 22 references indexed in Scilit:
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatmentLiver International, 2016
- Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry ProgramJournal of Cancer Epidemiology, 2014
- The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphomaExperimental Hematology & Oncology, 2013
- An insight into the diagnosis and pathogenesis of hepatitis C virus infectionWorld Journal of Gastroenterology, 2013
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective StudyThe Journal of Infectious Diseases, 2012
- Cellular fibronectin stimulates hepatocytes to produce factors that promote alcohol-induced liver injuryWorld Journal of Hepatology, 2011
- Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypesCancer Causes & Control, 2009
- Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemiaAnnals of the Rheumatic Diseases, 2008
- Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression informationBioinformatics, 2005
- Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survivalBlood, 2003